Octreotide Scintigraphy Periprocedural Care

Updated: Jun 09, 2016
  • Author: Bishnu Prasad Devkota, MD, MHI, FRCS(Edin), FRCS(Glasg), FACP; Chief Editor: Gowthaman Gunabushanam, MD, FRCR  more...
  • Print
Periprocedural Care

Pre-Procedure Planning

The patient’s pertinent history should be obtained, including the type of suspected primary or metastatic tumor, its endocrine status, results of other imaging modalities (eg, CT, MRI, tumor biomarkers), and history of chemotherapy, radiation therapy, recent surgery, and octreotide therapy. Cholecystectomy history should also be obtained. [1]

Next:

Patient Preparation

Patients should be well hydrated before and for at least one day after injection to decrease the radiation exposure. Octreotide therapy should be stopped for one day before 111In pentetreotide administration, while monitoring the patient for signs of withdrawal. When the abdomen is the area of interest, laxatives should be used to clean the bowels. A mild oral laxative should be used in the evening before and after the injection. The necessity for bowel preparation should be individualized, and, of course, laxatives should not be administered in patients with diarrhea. [1]

Previous